Both in Surgical Instruments
DexCom vs Boston Scientific
Over the past year DXCM returned +38.9% and BSX returned −55.5%; their daily moves had a correlation of 0.28.
DXCM +38.9% BSX −55.5%Growth of $1, one year, split-adjusted
| Metric | DXCM | BSX |
|---|---|---|
| Price | $83.94 | $43.92 |
| Market cap | $31.31B | $63.64B |
| Today | −0.97% | −0.91% |
| 1 month | −3.4% | +3.6% |
| 6 months | +41.1% | −21.6% |
| Year to date | +26.5% | −53.9% |
| 1 year | +44.2% | −56.4% |
| Revenue growth (YoY) | +11.2% | +7.5% |
| Gross margin | 64.3% | 70.7% |
| Net margin | 20.5% | 16.7% |
| P/E (TTM) | 31.6× | 17.3× |
| Price / sales | 6.1× | 3.0× |
| Net cash | $574.2M | -$12.09B |
| Dividend yield | — | — |
| Volatility (60d) | 29.1% | 36.2% |
| Short % of float | 4.2% | 2.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).